SummaryLentigo maligna (LM) incidence is increasing. LM frequently involves the face near critical anatomical structures and as a consequence clinical management is challenging. Nonsurgical therapies, including radiotherapy (RT), are increasingly used. Evidenced-based treatment guidelines are lacking. We conducted a review of previously published data analysing RT treatment of LM. A search of PubMed, Embase and Medline databases to June 2012 identified nine clinical studies that examined the use of RT for LM treatment in at least five patients. Nine studies described 537 patients with LM treated with definitive primary RT, between 1941 and 2009, with a median reported follow-up time of 3 years. Eight articles could be reviewed for oncological outcome data. There were 18 recurrences documented in a total of 349 assessable patients (5%). Salvage was successful in the majority of recurrent LM cases by using further RT, surgery or other therapies. Progression to LM melanoma (LMM) occurred in five patients (five out of 349, 1Á4%) who all had poor outcomes. There were five marginal recurrences documented out of 123 assessable patients (4%). There were eight in-field recurrences documented with either LM (five) or LMM (three) out of 171 assessable patients (5%). A series of recommendations were then developed for RT parameters for treatment of LM. These parameters include treatment volume, dose, dose per fraction and outcome measures. These may be of use in prospective data collection.
What's already known about this topic?• Radiotherapy is increasingly used for the treatment of lentigo maligna; however, there is a lack of evidence-based radiotherapy treatment guidelines.
What does this study add?• This is the first literature review of radiotherapy for lentigo maligna.• We have developed recommendations for radiotherapy of lentigo maligna based on the review and our own initial experience from a multidisciplinary lentigo maligna clinic.Lentigo maligna (LM), a form of in situ melanoma, 1-3 is characterized in its earliest stages by scattered single atypical melanocytes involving the dermoepidermal junction (Fig. 1a) and extending down skin appendageal structures. It usually occurs within severely sun-damaged skin. 4 As the tumour progresses, melanocyte density and degree of cytological atypia increase (Fig. 1b). Advanced cases of LM often show confluent growth of melanocytes along the basal epidermis, nest formation and pagetoid epidermal invasion, with florid adnexal involvement (Fig. 1c). The transition at the peripheral margin of the lesion from neoplastic to non-neoplastic melanocytes can be poorly defined.5,6